.

.

Banner consulta_NAGENpediatrics

.

Banner GEnomica Cima Universidad de Navarra

.

Banner equipoNAGENpediatrics

.

Banner Terapia Génica Cima Universidad de Navarra

.

Video gallery

European Digital Innovation Hub Navarra

Responsive Image

European Digital Innovation Hub Navarra – IRIS chaired by Government of Navarre and selected by the European Commission to be part of the first network of European Digital Innovation Hubs (EDIHs), acts as a catalyst for digital transformation, offering specialised services in Personalised Precision Medicine, High Performance Computing and Artificial Intelligence to companies and public entities at regional, national and European level.  

IRIS’ Service Catalogue: 

 

Latest news

CIMA imagen

Regional Minister Fanlo highlights Navarre's capacity and leadership in personalised medicine after visiting the novel Navarrabiomed facilities

During the day, the Minister chaired a meeting with research staff from the Genomic Medicine Unit in which she was able to learn about the progress of the NAGEN Program projects that the centre has been developing since 2016 and the Infrastructure for Precision Medicine associated with Science and Technology (IMPaCT), which is coordinated nationally by the Carlos III Institute of Health (ISCIII) and centralised in Navarre at Navarrabiomed.
Read more
El consejero Domínguez, junto con Alfredo Martínez, gerente del SNS-O, la gerente de Atención Primaria, Susana Miranda, y la directora de Navarrabiomed, Maite Mendioroz, investigadores del proyecto Cohorte IMPaCT, Patricia Palacio y Óscar Lecea y personal del Centro de Salud de Lezkairu.

4,000 people will participate in a study to learn why we get sick, improve prevention and move towards personalized precision medicine.

The Regional Minister of Health, Fernando Domínguez, presied today the presentation of the IMPaCT Cohort study at the Lezkairu health centre. This study aims to carry out an exhaustive health study of 200,000 people representative of the Spanish population over the next 20 years, 4,000 in Navarra, in order to better understand the origin of the main diseases, thus helping to prevent and treat them, promoting personalised and precision medicine. The event was also attended by Patricia Palacio and Óscar Lecea, principal investigator and collaborator of the study in Navarre, respectively, and the Primary Care manager, Susana Miranda.
Read more
CIMA imagen

Childhood cancer survival rate in Navarre remains at 80% thanks to personalised treatments

The Multidisciplinary Unit for Child and Adolescent Cancer (UMDCIA) of the University Hospital of Navarre diagnosed and treated a total of 22 new cases of cancer in 2023, all of them in patients aged between 1 month and 16 years.
Read more